Home › Compare › CMDRF vs MRK

CMDRF vs MRK: Dividend Comparison 2026

CMDRF yields 5000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMDRF wins by $62217131802825.32M in total portfolio value
10 years
CMDRF
CMDRF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full CMDRF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — CMDRF vs MRK

📍 CMDRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMDRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMDRF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CMDRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMDRF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, CMDRF beats the other by $50,882,683,244,271,480,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMDRF + MRK for your $10,000?

CMDRF: 50%MRK: 50%
100% MRK50/50100% CMDRF
Portfolio after 10yr
$31108565901412.69M
Annual income
$29,930,990,143,689,105,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CMDRF
No analyst data
Altman Z
14.5
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMDRF buys
0
MRK buys
0
No recent congressional trades found for CMDRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMDRFMRK
Forward yield5000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$62217131802825.35M ✓$30.7K
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$950.29
Total dividends collected$62057786341622.61M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CMDRF vs MRK ($10,000, DRIP)

YearCMDRF PortfolioCMDRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$510,700$500,000.00$11,192$351.54+$499.5K → CMDRF
2$24,410,935$23,864,485.98$12,524$392.70+$24.40M → CMDRF
3$1,092,192,501$1,066,072,800.30$14,015$438.65+$1092.18M → CMDRF
4$45,746,366,951$44,577,720,975.17$15,682$489.96+$45746.35M → CMDRF
5$1,793,932,828,410$1,744,984,215,772.56$17,547$547.23+$1793932.81M → CMDRF
6$65,871,973,805,320$63,952,465,678,921.49$19,632$611.16+$65871973.79M → CMDRF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$21,963$682.53+$2265146887.58M → CMDRF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$24,571$762.18+$72954689148.97M → CMDRF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$27,486$851.08+$2201076182660.86M → CMDRF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$30,745$950.29+$62217131802825.32M → CMDRF

CMDRF vs MRK: Complete Analysis 2026

CMDRF — Stock

Commander Resources Ltd. engages in the acquisition, exploration, and development of base and precious metal projects in Canada and Mexico. The company explores for gold, copper, nickel, and zinc deposits. It holds interests in the Flume property located in Yukon; Henry Lee, Omineca, Burn, Mt. Polley, and October Dome properties located in British Columbia; the First Loon and the Sabin properties located in Ontario; Nepisiguit property located in New Brunswick; and South Voisey's Bay property located in Labrador, as well as Pedro property located in Mexico. The company was founded in 1989 and is headquartered in Vancouver, Canada.

Full CMDRF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this CMDRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMDRF vs SCHDCMDRF vs JEPICMDRF vs OCMDRF vs KOCMDRF vs MAINCMDRF vs JNJCMDRF vs ABBVCMDRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.